Humana Inc. (NYSE:HUM) Shares Sold by Man Group plc

Man Group plc decreased its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 85.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 14,283 shares of the insurance provider's stock after selling 86,438 shares during the quarter. Man Group plc's holdings in Humana were worth $3,624,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HUM. Transcend Capital Advisors LLC boosted its stake in Humana by 399.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock worth $924,000 after buying an additional 2,914 shares during the last quarter. Retirement Systems of Alabama boosted its stake in Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock worth $55,563,000 after buying an additional 192,801 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Humana by 7.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock worth $244,811,000 after buying an additional 65,735 shares during the last quarter. Secure Asset Management LLC acquired a new position in Humana during the fourth quarter worth $244,000. Finally, denkapparat Operations GmbH acquired a new position in Humana during the fourth quarter worth $323,000. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Trading Up 0.7%

Shares of HUM stock traded up $1.56 on Tuesday, hitting $226.49. The stock had a trading volume of 1,555,319 shares, compared to its average volume of 1,779,731. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market capitalization of $27.34 billion, a P/E ratio of 22.76, a P/E/G ratio of 2.05 and a beta of 0.49. Humana Inc. has a 1 year low of $212.45 and a 1 year high of $406.46. The company's 50 day moving average price is $259.52 and its 200-day moving average price is $267.76.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.07 by $1.51. The firm had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. The company's quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $7.23 EPS. Analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, June 27th. This represents a $3.54 annualized dividend and a yield of 1.56%. Humana's dividend payout ratio (DPR) is 25.04%.

Analyst Ratings Changes

A number of research firms have weighed in on HUM. Morgan Stanley lowered their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 12th. Guggenheim began coverage on Humana in a research note on Wednesday, April 9th. They set a "buy" rating and a $326.00 price objective on the stock. JPMorgan Chase & Co. lowered their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. Mizuho upped their price target on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Finally, Wall Street Zen raised Humana from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Seventeen investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to MarketBeat.com, Humana presently has a consensus rating of "Hold" and an average price target of $286.81.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.